Crossmark

Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics

Crossref DOI link: https://doi.org/10.1186/s13075-021-02567-y

Published Online: 2021-07-06

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koo, Bon San

Eun, Seongho

Shin, Kichul

Yoon, Hyemin

Hong, Chaelin

Kim, Do-Hoon

Hong, Seokchan

Kim, Yong-Gil

Lee, Chang-Keun

Yoo, Bin

Oh, Ji Seon https://orcid.org/0000-0002-0205-6492
Funding

Funding for this research was provided by:

Asan Institute for Life Sciences, Asan Medical Center (2020IP0025)

Ministry of Trade, Industry and Energy (20004927)
License Information

Text and Data Mining valid from 2021-07-06

Version of Record valid from 2021-07-06
More Information

Article History

Received: 24 February 2021

Accepted: 27 June 2021

First Online: 6 July 2021

Declarations

:

: The patients provided informed consent prior to registration. Ethical approvals for the KOBIO-RA were obtained from the institutional review boards of all 38 participating institutions, including the Institutional Review Board of Inje University Seoul Paik Hospital (PAIK 2018-11-005).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below